Human Chorionic Gonadotropin as a Prognostic Factor in Kidney Cancer
Author Information
Author(s): Hotakainen K, Ljungberg B, Paju A, Rasmuson T, Alfthan H, Stenman U-H
Primary Institution: Helsinki University Central Hospital
Hypothesis
Does elevated human chorionic gonadotropin β levels predict clinical outcomes in renal cell carcinoma?
Conclusion
Elevated levels of human chorionic gonadotropin β in serum are associated with shorter survival in patients with renal cell carcinoma.
Supporting Evidence
- 23% of renal cell carcinoma patients had elevated hCGβ levels.
- Patients with hCGβ levels above the median had significantly shorter survival times.
- The median hCGβ concentration in patients was significantly higher than in healthy controls.
Takeaway
This study found that a hormone called human chorionic gonadotropin β can help doctors figure out how serious kidney cancer is, especially if the levels are high.
Methodology
Serum samples were collected from patients with renal cell carcinoma and analyzed for human chorionic gonadotropin β levels using a time-resolved immunofluorometric assay.
Limitations
The study's findings may not apply to all patients with renal cell carcinoma since only a subset showed elevated hCGβ levels.
Participant Demographics
The study included 177 patients (111 men and 66 women) with a mean age of 65 years.
Statistical Information
P-Value
0.0029
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website